Target intelligence / Profile preview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 35 (HNRNPA1P35)

Target
HNRNPA1P35
Molecular classification
Pseudogene, Other
01

Overview

Heterogeneous nuclear ribonucleoprotein A1 pseudogene 35 (HNRNPA1P35) is a processed pseudogene, not a functional protein-coding gene. Unlike the functional HNRNPA1, which encodes an RNA-binding protein involved in pre-mRNA processing and cancer biology, HNRNPA1P35 is classified as a pseudogene and is not known to have biological activity or therapeutic relevance[1][3]. There is no current evidence to suggest that HNRNPA1P35 serves as a direct target for drugs, no known disease association, and no described biological function or mechanistic relevance. Key context: - HNRNPA1P35 is annotated as a processed pseudogene in genomic databases (e.g., Ensembl ENSG00000225695, HGNC:48764)[1][3]. - Pseudogenes do not produce functional proteins and generally do not serve as therapeutic targets. - Confusion may arise with the functional HNRNPA1 gene/protein, which is involved in RNA regulation and cancer, but HNRNPA1P35 specifically is a pseudogene and not a target of interest for drug development or biomarker studies[1][3].

Other names
HNRNPA1P35

Beyond the preview

Go deeper on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 35 (HNRNPA1P35).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 35 (HNRNPA1P35).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call